Understanding risk and lessons for clinical risk communication about treatment preferences
about
Doctors and patients' susceptibility to framing bias: a randomized trialCommunicating risk and promoting disease mitigation measures in epidemics and emerging disease settingsThe importance of patient preferences in treatment decisions--challenges for doctors.Importance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paperAmbivalence related to potential lifestyle changes following preventive cardiovascular consultations in general practice: a qualitative studyReal life clinic visits do not match the ideals of shared decision makingConsidering culture in physician-- patient communication during colorectal cancer screeningTraining recruiters to randomized trials to facilitate recruitment and informed consent by exploring patients' treatment preferencesThe extent of patients' understanding of the risk of treatmentsInformed consent: moral necessity or illusion?Conceptual problems in laypersons' understanding of individualized cancer risk: a qualitative study.Factors influencing cancer risk perception in high risk populations: a systematic review.Homeless drug users' awareness and risk perception of peer "take home naloxone" use--a qualitative studyThreats to the estimation of benefit: are preference elicitation methods accurate?Exploring treatment preferences facilitated recruitment to randomized controlled trials.How should we measure informed choice? The case of cancer screening.Comparison of two methods of presenting risk information to patients about the side effects of medicines.Differences in belief about likely outcomes account for differences in doctors' treatment preferences: but what accounts for the differences in belief?Preferences for Analgesic Treatments Are Influenced by Probability of the Occurrence of Adverse Effects and the Time to Reach Maximal Therapeutic Effects.Genetic testing and genetic counseling among Medicaid-enrolled children with autism spectrum disorder in 2001 and 2007.Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis.Using discounting biases, risk characteristics, and perceived control improves preventive programs.Individual health discount rate in patients with ulcerative colitis.Event-based versus process-based informed consent to address scientific evidence and uncertainties in ionising medical imaging.'I should have taken that further' - missed opportunities during cardiovascular risk assessment in patients with psoriasis in UK primary care settings: a mixed-methods study.Decision aids for familial breast cancer: exploring women's views using focus groupsAssessing and improving research participants' understanding of risk: potential lessons from the literature on physician-patient risk communication.Understanding and assessing potential serious adverse events: a practical approach to understanding the benefits and harm of psoriasis treatments.Informed consent for anesthesia: a review of practice and strategies for optimizing the consent process.The incidental pulmonary nodule in a child. Part 2: Commentary and suggestions for clinical management, risk communication and prevention.A Note on the Validity and Reliability of Multi-Criteria Decision Analysis for the Benefit-Risk Assessment of Medicines.Risk communication in the dental practice.Effective doses and standardised risk factors from paediatric diagnostic medical radiation exposures: Information for radiation risk communication.Concepts for communication about risk in dementia care: A review of the literature.The communication of the radiation risk from CT in relation to its clinical benefit in the era of personalized medicine: part 2: benefits versus risk of CT.Personalized risk communication for personalized risk assessment: Real world assessment of knowledge and motivation for six mortality risk measures from an online life expectancy calculator.Using a graphical risk tool to examine willingness to take migraine prophylactic medications.Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis.Good clinical practice and informed consent are inseparable.Understanding patients' preferences for treatment: the need for innovative methodologies.
P2860
Q24629858-E005EB45-A872-4C5E-B4FD-6F856E7C0ADFQ26823147-50B69B72-1A72-4538-8A79-AF138AD1839CQ27319973-798C7F6B-48AE-47B2-B99C-768D15A9A3C1Q28188630-EF41F5E4-1AC5-41C8-A179-2176558BDA9EQ33369225-805CC313-13B2-452C-9E4D-D99CA5B9C369Q33931784-153C07B6-AE6E-4592-8BF2-159DEE93BDB7Q34066807-EE7E573E-F4E3-427F-B0B0-EDE0C74745FDQ34067540-00071058-F755-4212-B1C2-14554029839CQ34354182-D38F5C06-EF7D-47F5-9A60-3A86071F6EC9Q34354187-FF9A3401-9D91-4EF0-8974-CB43B86BB301Q34378266-C61EBD35-3BDE-4904-8ADF-C4553D3610C5Q35056613-0AF90938-0DC8-4629-BB80-68D69FD93A96Q35079876-669AD9D2-9D7F-4245-A0F8-30074FE2D6A5Q35116977-7B7641DB-D64B-4318-993B-3CD1D05759D5Q35197425-93C06720-3114-4FD2-82D7-AF382E2EC1EEQ35429513-E023B253-6076-4A2B-BEC3-5764A9FA8150Q35526926-F350B664-CBBD-4FC4-84EB-69A7AF7E6E01Q35576733-26203412-972A-40FE-AB0F-D6E3C7E3A212Q35661643-4297F1FF-003A-4DF8-A514-8208CDE3AB9FQ36614115-494B01DB-E8D5-453D-906B-3DD10FE15281Q36663691-74C4EE8F-D979-448F-8561-AF85243E00ECQ36735265-AF4A7E9D-F2ED-4819-B18E-D2E6DC72A24AQ36745006-E9E93B47-DBF0-45CE-A30A-9C24F49BFCA8Q37192824-C46E8D18-C86E-477A-9799-ADB41C224C17Q37316423-F46DF3DC-1353-4969-B7AA-14D619C0CF83Q37332011-4164A53B-0424-4241-ACAB-96A89DDA7775Q37455006-36CCB986-D701-4127-8928-68761C906A21Q38106807-8F849BD0-B8AC-46D8-BC90-6B1BE3E53C05Q38217734-89044A05-CA8B-47A5-BBDC-4E7063684E47Q38345460-1A8D2489-4475-4344-840F-F719D80C1DC2Q38583668-FE5E9728-1F11-4298-8E07-68298D32484CQ38705644-2BF93875-07CC-44D7-A4F6-BEC842409C00Q38744085-10AC32D7-752C-42F6-9B61-E94B3FFFB85AQ38834372-2AD48309-956C-481D-9088-B03D4CC3162EQ39115257-0AE12C9E-83DE-4F13-8664-77D18FEC25C7Q40389284-9435CF63-F6D9-4AAF-B96A-D8575EDD6730Q41655641-DBC6BFE7-0371-450B-A1DC-2932D65C67E2Q41854298-FDEFAC55-CF4E-44BF-A3AE-50805C9B1374Q43017138-040E620A-D823-4BE5-85D2-D48B57382B97Q43021068-D1BF1726-346E-44AB-8E4A-811970989235
P2860
Understanding risk and lessons for clinical risk communication about treatment preferences
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Understanding risk and lessons ...... on about treatment preferences
@ast
Understanding risk and lessons ...... on about treatment preferences
@en
Understanding risk and lessons ...... on about treatment preferences
@nl
type
label
Understanding risk and lessons ...... on about treatment preferences
@ast
Understanding risk and lessons ...... on about treatment preferences
@en
Understanding risk and lessons ...... on about treatment preferences
@nl
prefLabel
Understanding risk and lessons ...... on about treatment preferences
@ast
Understanding risk and lessons ...... on about treatment preferences
@en
Understanding risk and lessons ...... on about treatment preferences
@nl
P2860
P356
P1476
Understanding risk and lessons ...... on about treatment preferences
@en
P2093
P2860
P356
10.1136/QHC.0100009
P478
10 Suppl 1
P577
2001-09-01T00:00:00Z